Low sevoflurane
PreclinicalSmall molecule
Low sevoflurane is one of 3 small molecule programs targeting Post Operative Sore Throat. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Post Operative Sore Throat
#DrugCompanyPhaseTrials
1Ultram
WWim Janssens
Approved
Xylocaine
AstraZenecaPhase 3
Low sevoflurane
KKeimyung University Dongsan Medical Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Low sevoflurane. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details